350
Participants
Start Date
June 17, 2021
Primary Completion Date
September 15, 2024
Study Completion Date
November 6, 2024
Vernakalant
an initial infusion of 3 mg/kg infused over a 10-minute period by a pre-programmed IV pump
Procainamide
15 mg/kg in 500 mL of normal saline given over 60 minutes
University of Alberta Hospital, Edmonton
Vancouver General Hospital, Vancouver
St. Paul's Hospital, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
St. Michaels, Toronto
Sunnybrook Hospital, Toronto
Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Laval
Hopital Du Sacre-Coeur, Montreal
Hopital de L'Enfant-Jesus, Québec
Hôtel-Dieu de Lévis, Québec
Hamilton Health Sciences Centre, Hamilton
Kingston Health Sciences Centre, Kingston
Ottawa Hospital, Ottawa
Montreal Heart Institute, Montreal
Lead Sponsor
Ottawa Hospital Research Institute
OTHER